The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Empowered Funds LLC

Empowered Funds LLC grew its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 8.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,086 shares of the medical device company’s stock after purchasing an additional 248 shares during the period. Empowered Funds LLC’s holdings in Cooper Companies were worth $341,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of COO. Envestnet Portfolio Solutions Inc. lifted its position in Cooper Companies by 43.1% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock valued at $3,076,000 after purchasing an additional 10,616 shares during the period. Diversify Advisory Services LLC purchased a new stake in shares of Cooper Companies in the second quarter valued at approximately $501,000. BDF Gestion purchased a new stake in shares of Cooper Companies in the second quarter valued at approximately $2,919,000. Assenagon Asset Management S.A. grew its holdings in Cooper Companies by 30.9% during the second quarter. Assenagon Asset Management S.A. now owns 535,909 shares of the medical device company’s stock worth $46,785,000 after acquiring an additional 126,371 shares during the period. Finally, Victory Capital Management Inc. raised its position in Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after acquiring an additional 737,726 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on COO. Robert W. Baird increased their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Wells Fargo & Company lifted their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Morgan Stanley lifted their price target on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the transaction, the chief operating officer now directly owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 72.01 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. This trade represents a 78.94 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock valued at $27,637,427 in the last ninety days. Insiders own 2.00% of the company’s stock.

Cooper Companies Price Performance

COO stock opened at $102.40 on Tuesday. The company has a market cap of $20.39 billion, a PE ratio of 57.05, a price-to-earnings-growth ratio of 2.17 and a beta of 0.99. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The stock has a 50-day moving average price of $105.74 and a two-hundred day moving average price of $98.39. The Cooper Companies, Inc. has a 12-month low of $82.21 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. During the same quarter last year, the firm posted $0.84 EPS. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.